National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 333084

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2008

VAERS ID: 333084
VAERS Form:
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 - / PO

Administered by: Other      Purchased by: Unknown
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type':

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception"at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via


Changed on 12/8/2009

VAERS ID: 333084 Before After
VAERS Form:
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 - / PO

Administered by: Other      Purchased by: Unknown Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': (blank) WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception"at intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 5/13/2013

VAERS ID: 333084 Before After
VAERS Form:
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 - / PO
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 9/14/2017

VAERS ID: 333084 Before After
VAERS Form:(blank) 1
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 2 - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 2/14/2018

VAERS ID: 333084 Before After
VAERS Form:1
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 6/14/2018

VAERS ID: 333084 Before After
VAERS Form:1
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 8/14/2018

VAERS ID: 333084 Before After
VAERS Form:1
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 9/14/2018

VAERS ID: 333084 Before After
VAERS Form:1
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.


Changed on 10/14/2018

VAERS ID: 333084 Before After
VAERS Form:1
Age:0.5
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Barium double contrast, Diarrhoea, Intussusception, Lethargy, Pallor, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, air contrast enema-complete reduction
CDC 'Split Type': WAES0811USA02628

Write-up: Information has been received from an investigator concerning a 6 month old female who was vaccinated PO with her second dose of ROTATEQ. This report was part of a post-marketing surveillance program. The patient experienced ileocecalcolic intussusception at hepatic flexure characterized by sudden onset severe, colicky abdominal pain, yellowish vomiting, loose stool and some lethargy and pallor 53 days after vaccination and was hospitalized for 2 days. Possible complete reduction of the intussusception via air contrast enema was evidenced by dramatic immediate clinical improvement. The patient was discharged on day 2 and the outcome was noted to be recovering. At this time, relationship of ileocecalcolic intussusception to study therapy is unknown. Ileocecalcolic intussusception was considered to be an other important medical event (enema) by the reporter. Additional information has been requested.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=333084&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166